Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · IEX Real-Time Price · USD
0.365
-0.066 (-15.31%)
At close: Jul 2, 2024, 4:00 PM
0.406
+0.041 (11.32%)
After-hours: Jul 2, 2024, 6:38 PM EDT

Traws Pharma Revenue

Traws Pharma had revenue of $226.00K in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $56.00K. In the year 2023, Traws Pharma had annual revenue of $226.00K.

Revenue (ttm)
$226.00K
Revenue Growth
n/a
P/S Ratio
40.86
Revenue / Employee
$13,294
Employees
17
Market Cap
9.23M

Revenue Chart

* The company reports in USD currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023226.00K--
Dec 31, 2022226.00K--
Dec 31, 2021226.00K-5.00K-2.16%
Dec 31, 2020231.00K-1.95M-89.42%
Dec 31, 20192.18M955.00K77.77%
Dec 31, 20181.23M441.00K56.04%
Dec 31, 2017787.00K-4.76M-85.81%
Dec 31, 20165.55M-5.91M-51.59%
Dec 31, 201511.46M10.66M1,332.00%
Dec 31, 2014800.00K-3.95M-83.17%
Dec 31, 20134.75M-41.44M-89.71%
Dec 31, 201246.19M44.70M3,006.25%
Dec 31, 20111.49M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Centogene 53.93M
RedHill Biopharma 6.53M
Elevai Labs 2.18M
Addex Therapeutics 1.57M
Innovative Eyewear 1.39M
Alaunos Therapeutics 5.00K
Revenue Rankings